Spexis AG / Key word(s): Annual Results Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, March 9, 2022 Spexis AG (SIX: SPEX) announced today that it will publish its full-year financial results for 2021 on March 24 at 7.30am CET. Jeffrey D. Wager, M.D. (CEO & Chairman) and Hernan Levett (CFO) will host an earnings call at 2.30pm CET, together with Juergen Froehlich, M.D. (CMDO) and Stephan Wehselau (COO). To access the earnings call, please use the following details: France: +33 (0)1 70 730 3 39 Event Title: Spexis AG - Strategy Update and 2021 Financial Results Confirmation code: 4015509 After the call, the presentation will be available via the above link. For further information please contact:
About Spexis Disclaimer Additional features: File: Spexis to announce FY2021 Financial Results End of ad hoc announcement |
Language: | English |
Company: | Spexis AG |
Hegenheimermattweg 125 | |
4123 Allschwil | |
Switzerland | |
Phone: | +41 61 567 1600 |
Fax: | +41 61 567 1601 |
E-mail: | info@spexisbio.com |
Internet: | www.spexisbio.com |
ISIN: | CH0106213793 |
Valor: | SPEX |
Listed: | SIX Swiss Exchange |
EQS News ID: | 1297747 |
End of Announcement | EQS News Service |
|
1297747 09-March-2022 CET/CEST
Ad-hoc announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.